Dassault Systèmes today announced that a beta test is underway to evaluate a new generation of the Living Heart model that can be customized for individual patients or patient populations. The test aims to deliver a level of configuration and automation that makes the model an improved resource for simplifying medical device research and development.
Members of the Living Heart Project are testing the creation of customized models that offer the ability to adjust tissue properties, structural variations and other aspects. Because this new generation builds upon the project’s years of experience with real patients, its insight into human physiology enables it to create thousands of virtual patient twins and be used as a training set for generative AI. Researchers and clinicians can understand a disease and how a patient population will react to a given treatment, without using humans or animals, and without privacy or profile constraints.
The beta test of the new generation Living Heart model follows the release of the “ENRICHMENT Playbook,” a guide for the medical device industry that outlines how to use virtual twins to accelerate clinical trials. The validation and the efficiency of virtual twins provide benefits across biopharma, hospitals, medical devices, wearables and public health.
The company announced the beta test today at its 3DEXPERIENCE World event in Houston, and explored expanding virtual twin applications to other organs to address a wider range of medical challenges.
